Prevalence of hypokalemia in patients with methylprednisolone pulse therapy;Prevalencia de hipokalemia en pacientes tratados con pulsos de metilprednisolona

Revista de Investigacion Clinica

Volumn 61, Issue 3, 2009, Pages 194-197

  Tamez Pérez, Héctor Eloy ^a,c,d   Cisneros Pérez, Vicente ^b   Cedillo Rodríguez, Javier Armando ^a   Díaz De León González, Enrique ^a   Torres Valenzuela, Miguel ^b   Tamez Peña, Alejandra Lorena ^c   Forsbach Sánchez, Gerardo ^a   Gutiérrez Hermosillo, Hugo ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^c Universidad Autonome de Nuevo León   (Mexico)

^d NONE   (Mexico)

Author keywords

Cardiac arrhythmias; Hypokalemia; Methylprednisolone pulse; Serum electrolytes; Steroids

Indexed keywords

METHYLPREDNISOLONE; POTASSIUM;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG PULSE THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PREVALENCE;

EID: 70349210427     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Williams GH, Dluhy RG. Enfermedades de la corteza suprarrenal. En: Fauci, Braunwald, Kasper, Hauser, Longo, Janeson, Loscalzo (eds.). Harrison Principios de Medicina Interna 17a Ed. México: Mc Graw Hill Interamericana; 2008, p. 2247-2269
2. Marcocci C, Baretelena L, Tanda M, Manetti L, Dell'unto E, Rocchi R, Barbesino G, et al. Comparison of the Effectiveness and Tolerability of Intravenouns or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophtalmopathy: Results of a Prospective, Single-Blind, Randomized Study. J Clin Endocrinol Metab 2001; 86: 3562-3567 (Pubitemid 32755944)
3. Garret R, Paulus H. Complications on intravenous methylprednisolone pulse therapy. Arthritis Rheum 1980; 23: 677. (Pubitemid 10064874)
4. Miyashita Y, Monden T, Yamamoto K, Matsumura M, Kawagaoe N, Iwata C, et al. Ventricular Fibrillation Due to Severe Hypokalemia Induced by Steroid Treatment in a Patient with Thyrotoxic Periodic Paralysis. Intern Med 2006; 45: 11-13 (Pubitemid 43205154)
5. Rojeau JC. Pulse glucocorticoid in Therapy. The "big shot" revisited. Arch Dermatol 1996; 132(12): 1499-1502
6. Gennari F. Hypokalemia. N Engl J Med 1998; 339: 451-458
7. Schaefer TJ, Wolford RW. Disorders of potassium. Emerg Med Clin North Am 2005; 23(3) 723-747
8. Paltiel O, Salakov E, Ronen I, Berg D, Israeli A. Management of Severe hypokalemia in Hospitalized Patients. Arch Intern Med 2001; 161(8): 1089-1095
9. Juchet H, Arlet P, Oilier S, Montane de la Roque P, Le Tallec Y. Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids. Ann Med Interne (Paris) 1992; 143(2): 85-88
10. Peters ND, Ejstrup L. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Scand J Rheumatol 1992; 21(3): 134-138
11. Mignogna MD, Lo Muzio L, Ruoppo E, Fedele S, Lo Russo L, Bucci E. High-dose Intravenous pulse methylprednisolone in the treatment of severe oropharingeal pemphigus: a pilot study. J Oral Pathol Med 2002; 31(6): 339-344 (Pubitemid 34896034)
12. Hoch S, Schur PH. Methylprednisolone pulse therapy for lupus nephritis: a follow up study. Clin Exp Rheumatol 1984; 2(4): 313-320 (Pubitemid 15180577)
13. Feldman-Billiard S, Lissak B, Benrabah R, Heron E. Intravenous pulse methylprednisolone therapy in eye disease: effect on glucose tolerance. Ophtalmology 2003; 110(12): 2369-2371 (Pubitemid 37485168)
14. Roden DM. Drug-Induced Prolongation of the QT Interval. N Engl J Med 2004; 350: 1013.
15. Chibane S, Feldman-Billard S, Rossignol I, Kassaei R, Mihoubi-Mantout F, Heron E. Short-term tolerance of three days pulse methylprednisolone therapy: a prospective study in 146 patients. Rev Med Interne 2005; 26(1): 20-26
16. Paltiel O, Salakhov E, Ronen I, Berg D, Israeli A. Management of Severe Hypokalemia in Hospitalized Patients A Study of Quality of Care Based on Computerized Databases. Arch Intern Med 2001; 161: 1089-1095 (Pubitemid 32685535)
17. Wongraoprasert S, Buranasupkajorn P, Sridama V, Snabbon T. Thyrotoxic periodic paralysis induced by pulse methylprednisolone. Intern Med 2007; 46: 1431-1433 (Pubitemid 47455769)
18. Menon V, Mehrotra A, Saxena R, Jaffery NF. Comparative evaluation of dexametasone for treatment of primary typical optic neuritis. Indian JC 2007; 55: 355-359
19. Tamez Pérez HE, Gutiérrez Hermosillo H, Cedillo Rodriguez J, Mora Torres N, Hernández Coria M, Gómez de Ossio M. Tratamiento con insulina en el paciente hospitalizado con diabetes mellitus tipo 2 ¿única opción? Med Int Mex 2007; 23: 196-199